| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.33B | 19.90B | 19.65B | 21.21B | 21.09B | 22.88B |
| Gross Profit | 5.86B | 5.53B | 5.21B | 5.52B | 5.54B | 6.24B |
| EBITDA | 2.17B | 2.03B | 1.91B | 2.31B | 2.32B | 2.84B |
| Net Income | 1.28B | 1.16B | 888.24M | 1.21B | 1.07B | 1.47B |
Balance Sheet | ||||||
| Total Assets | 30.03B | 31.91B | 31.18B | 30.46B | 29.13B | 29.50B |
| Cash, Cash Equivalents and Short-Term Investments | 10.86B | 14.09B | 11.57B | 12.21B | 11.90B | 13.22B |
| Total Debt | 164.15M | 4.11M | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 2.62B | 3.97B | 4.09B | 4.37B | 4.06B | 5.07B |
| Stockholders Equity | 27.40B | 27.94B | 27.09B | 26.10B | 25.07B | 24.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.37B | -267.67M | 1.48B | -319.50M | 5.24B |
| Operating Cash Flow | 0.00 | 2.82B | 111.10M | 2.02B | 546.39M | 5.53B |
| Investing Cash Flow | 0.00 | -2.95B | -893.50M | -1.36B | -2.01B | -290.82M |
| Financing Cash Flow | 0.00 | -356.11M | -355.67M | -355.92M | -355.49M | -355.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥16.75B | 2.31 | ― | 2.30% | 9.86% | 119.10% | |
76 Outperform | ¥512.74B | 11.76 | 8.51% | 2.25% | 3.33% | 9.57% | |
67 Neutral | ¥66.69B | 31.55 | 1.61% | 2.27% | 1.82% | -32.79% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥28.11B | 3.93 | ― | 2.94% | 0.41% | -51.02% | |
54 Neutral | ¥4.28B | -27.75 | ― | 3.25% | -1.20% | -1136.47% | |
45 Neutral | ¥5.22B | -3.62 | ― | ― | -23.54% | -14.54% |